Your browser doesn't support javascript.
loading
Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients.
Harrysson, Sara; Eloranta, Sandra; Ekberg, Sara; Enblad, Gunilla; El-Galaly, Tarec C; Sander, Birgitta; Sonnevi, Kristina; Andersson, Per-Ola; Jerkeman, Mats; Smedby, Karin E.
Afiliação
  • Harrysson S; Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Eloranta S; Department of Hematology, Karolinska University Hospital, Solna, Sweden.
  • Ekberg S; Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Enblad G; Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • El-Galaly TC; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Sander B; Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Sonnevi K; Department of Hematology, Aalborg University Hospital, Aalborg, Denmark.
  • Andersson PO; Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
  • Jerkeman M; Department of Hematology, Karolinska University Hospital, Solna, Sweden.
  • Smedby KE; Department of Hematology, South Älvsborg Hospital, Borås, Sweden.
Br J Haematol ; 198(2): 267-277, 2022 07.
Article em En | MEDLINE | ID: mdl-35468219

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Linfoma Difuso de Grandes Células B / Transplante de Células-Tronco Hematopoéticas / Receptores de Antígenos Quiméricos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Linfoma Difuso de Grandes Células B / Transplante de Células-Tronco Hematopoéticas / Receptores de Antígenos Quiméricos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia